Ellipses Pharma is taking a different approach. Ellipses, a developer of innovative cancer medicines, has built a cloud-based platform to crowdsource scientific and clinical insight from a large ...

Ellipses is performing CMC (chemistry, manufacturing, and controls), formulation, and IND-enabling studies on EP0023. EP0023 has the potential for orphan drug designation in multiple MMP14 ...